Covid19 Clinical Trials Database - Free Access to 950 Studies
Access comprehensive clinical trial information for Covid19 through Pure Global AI's free database. This collection includes 950 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 333 trials are actively recruiting participants.
Research for Covid19 is being conducted in United States of America, France, Egypt and 7+ other countries. Leading sponsors include Assiut University and Sorrento Therapeutics, Inc.. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Model to Predict Coinfection in Elderly Patients With COVID-19
COVID-19 Personal Protective Equipment for Vaccinated Health Workers and Convalescents
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)
KAND567 Versus Placebo in Subjects Hospitalized With COVID-19
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600)
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100)
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine)
Cluster-Randomized Trial of Air Filtration and Ventilation to Reduce Covid19 Spread in Homes
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400)
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone)
Analysis of Breathing Pattern Post COVID-19
COVID-19 Citizen Science Expansion Project
EFFECTS OF INSPIRATORY MUSCLE TRAINING IN POST-COVID-19 PATIENTS
Relative Bioavailability, Safety, and Tolerability of Single-dose Sotrovimab Injection in Adults (COSMIC)
To Evaluate Safety & Immunogenicity of DelNS1-2019-nCoV-RBD-OPT1 for COVID-19 in Healthy Adults Received 2 Doses of BNT162b2
Face Masks to Reduce SARS-CoV-2 Infections (COVID-19) in Bangladesh
Sotrovimab Expanded Access Treatment Protocol (COVID-19)
Conversations You Want About Corona Virus Disease (COVID-19)
Novaferon in Non-hospitalized Adult Patients With Mild COVID-19
Pure Global AI provides free access to 950 clinical trials studying Covid19, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Assiut University, Sorrento Therapeutics, Inc., Assistance Publique - Hôpitaux de Paris, among others.